PetMed Express CFO granted 32,500 RSUs, PSUs

KRULIK DOUGLAS reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

KRULIK DOUGLAS reported acquisition or exercise transactions in this Form 4 filing.

PetMed Express granted CAO and interim CFO Douglas Krulik 32,500 shares of restricted common stock and 32,500 performance share units as equity compensation. The restricted shares vest 50% on June 26, 2027 and 50% on June 26, 2028, while the performance units payout depends on three-year relative total shareholder return through December 31, 2028.

Insider Trade Summary

Grant/Award: 65,000 shares

Grant/Award 2 txns

Insider KRULIK DOUGLAS

Role CAO and Interim CFO

Type	Security	Shares	Price	Value
Grant/Award	Performance Share Units	32,500	$0.00	$0.00
Grant/Award	Common Stock	32,500	$0.00	$0.00

Holdings After Transaction: Performance Share Units — 32,500 contracts (Direct); Common Stock — 102,500 shares (Direct)

Footnotes (2)

1. F1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.
2. F2. Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2028.

Key Figures

Restricted stock grant: 32,500 shares Performance share units granted: 32,500 units Shares owned after grant: 102,500 shares +2 more

5 metrics

Restricted stock grant 32,500 shares Common Stock granted June 26, 2026; vests 2027 and 2028

Performance share units granted 32,500 units PSUs tied to relative total shareholder return through Dec 31, 2028

Shares owned after grant 102,500 shares Total PetMed Express common stock held directly after restricted grant

PSU performance period end December 31, 2028 Three-year TSR performance period for PSU payout determination

PSU expiration date December 31, 2028 Expiration date listed for performance share units

Key Terms

Performance Share Units, total shareholder return, S&P 600 Specialty Retail Index, 2024 Omnibus Incentive Plan

4 terms

Performance Share Units financial

"Performance Share Units ("PSUs") granted pursuant to the Plan."

Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.

total shareholder return financial

"predetermined levels of the Company's total shareholder return relative to the S&P 600"

Total shareholder return is the overall gain an investor gets from owning a stock, combining changes in the share price plus any cash payouts like dividends, and assuming those payouts are reinvested in more shares. Investors use it like a single score that shows the true return on their investment—similar to checking both the growth of a savings account and the interest earned—to compare how well different companies or investments perform over time.

S&P 600 Specialty Retail Index financial

"relative to the S&P 600 Specialty Retail Index are achieved over a three-year"

2024 Omnibus Incentive Plan financial

"made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did PETS executive Douglas Krulik report on this Form 4?

Douglas Krulik, CAO and interim CFO of PetMed Express, reported receiving equity awards. He was granted 32,500 restricted common shares and 32,500 performance share units as compensation, with no cash paid, increasing his direct equity-based exposure to the company’s stock.

How many PetMed Express (PETS) shares does Douglas Krulik hold after these grants?

After the restricted stock grant, Douglas Krulik directly holds 102,500 shares of PetMed Express common stock. In addition, he holds 32,500 performance share units, which may convert into common shares depending on future performance conditions over the specified measurement period.

How do Douglas Krulik’s restricted PetMed Express (PETS) shares vest?

The 32,500 restricted PetMed Express common shares vest in two equal installments. Fifty percent vest on June 26, 2027 and the remaining fifty percent on June 26, 2028, subject to Krulik’s continued employment through each applicable vesting date under the 2024 Omnibus Incentive Plan.

What determines payout of Douglas Krulik’s PetMed Express (PETS) performance share units?

The 32,500 performance share units represent a contingent right to common shares. Payout depends on PetMed Express’s total shareholder return relative to the S&P 600 Specialty Retail Index over a three-year performance period ending December 31, 2028, based on predetermined performance levels.

What type of equity plan governs Douglas Krulik’s new PETS awards?

Both the restricted stock and performance share units were granted under the PetMed Express 2024 Omnibus Incentive Plan. This plan authorizes equity-based compensation such as restricted stock and performance units, aligning executive incentives with long-term shareholder returns and company performance objectives.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KRULIK DOUGLAS

(Last) (First) (Middle)

C/O PETMED EXPRESS, INC.

420 SOUTH CONGRESS AVENUE

(Street)

DELRAY BEACH FLORIDA 33445

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PETMED EXPRESS INC [ PETS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CAO and Interim CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/26/2026		A		32,500(1)	A	$0	102,500	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Units	(2)	06/26/2026		A		32,500		(2)	12/31/2028	Common Stock	32,500	$0	32,500	D

Explanation of Responses:

1. Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to 50% of granted shares on June 26, 2027, and 50% on June 26, 2028, subject to continued employment through each such vesting date.

2. Performance Share Units ("PSUs") granted pursuant to the Plan. Each PSU represents a contingent right to receive one share of the Company's Common Stock if predetermined levels of the Company's total shareholder return relative to the S&P 600 Specialty Retail Index are achieved over a three-year performance period ending on December 31, 2028.

Remarks:

	/s/ Douglas Krulik	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)